Keywords: biosafety
Ghana publishes its guidelines on Genome EditingAnonymous, BusinessGhana, 2023.Ghana's National Biosafety Authority (NBA) has published its guidelines on Genome Editing and Gene Stacks with regards Genetically Modified Organisms (GMOs) joining Nigeria, Kenya, and Malawi, as the fourth country in Africa with the guidelines. Genome editing is an emerging and ... Keywords: biosafety, gene drive synthetic, National Institutes of Health, policy, regulation, risk |
|
GMOs in Africa: Status, adoption and public acceptanceL. A. Gbadegesin, E. A. Ayeni, C. K. Tettey, V. A. Uyanga, O. O. Aluko, J. K. Ahiakpa, C. O. Okoye, J. I. Mbadianya, M. A. Adekoya, R. O. Aminu, F. P. Oyawole and P. Odufuwa, Food Control, 141:109193. 2022.Globally, genetically modified (GM) crops contribute to food security by increasing crop yield, quality and shelf-life. The commercialisation and adoption of GM crops in many developed countries raised hope of improving food security and livelihood. Africa, a developing continent ... Keywords: biosafety, gene drive synthetic, National Institutes of Health, policy, regulation, risk |
|
Laboratory Containment of Arthropods Capable of Gene Drive: Best Practices and RecommendationsHector Quemada, GeneConvene Global Collaborative, 2022.This webinar is presented by members of the American Society of Tropical Medicine and Hygiene's American Committee of Medical Entomologists who were involved in drafting a recent Addendum to the ASTMH's Arthropod Containment Guidelines that specifically consider arthropods with ... Keywords: biosafety, gene drive synthetic, National Institutes of Health, policy, regulation, risk |
|
Laboratory Biosafety in Handling Genetically Modified MosquitoesJ. Charles, Genetically Modified and other Innovative Vector Control Technologies, 2021.One of the novel approaches in controlling vector-borne diseases is to release genetically modified mosquitoes in nature. Trial studies are done in different phases by the researches, both in the laboratory and in the fields. Before a GM mosquito is validated to be ready for ... Keywords: biosafety, gene drive synthetic, National Institutes of Health, policy, regulation, risk |
|
Commercial Release of Genetically Modified Crops in Africa: Interface Between Biosafety Regulatory Systems and Varietal Release SystemsO. Akinbo, S. Obukosia, J. Ouedraogo, W. Sinebo, M. Savadogo, S. Timpo, R. Mbabazi, K. Maredia, D. Makinde and A. Ambali, Frontier in Plant Sciences, 12. 2021.African countries face key challenges in the deployment of GM crops due to incongruities in the processes for effective and efficient commercial release while simultaneously ensuring food and environmental safety. Against the backdrop of the preceding scenario, and for the ... Keywords: biosafety, gene drive synthetic, National Institutes of Health, policy, regulation, risk |
|
Emergent challenges for CRISPR: biosafety, biosecurity, patenting, and regulatory issuesBraddick, D. , and Ramarohetra, R. F., Genome Engineering Via Crispr-Cas9 System, 2021.The recent advancements of CRISPR-Cas technologies have transformed this simple and efficient gene editing technique into an extraordinarily powerful tool. The most anticipated applications could create novel therapeutics against mankind's most serious afflictions and help ... Keywords: biosafety, gene drive synthetic, National Institutes of Health, policy, regulation, risk |
|
Novel and Exceptional Technology and Research Advisory Committee – NExTRAC -NIHNIH Office of Science Policy, National Institutes of Health (NIH), 2020.NExTRAC provides advice to the Director of the National Institutes of Health (NIH) on matters related to the conduct and oversight of research involving emerging technologies in biomedical science. NExTRAC also makes recommendations on research involving the use of, and ... Keywords: biosafety, gene drive synthetic, National Institutes of Health, policy, regulation, risk |
Contact
David O’Brochta
Foundation for the
National Institutes of Health
geneconvenevi@fnih.org
RSS